Haemonetics (HAE) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.53 -2.21%
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.77, $0.07 better than the analyst estimate of $0.70. Revenue for the quarter came in at $304 million versus the consensus estimate of $290.79 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- C.H. Robinson acquires DeSpir Logistics for $75 million
- Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
